Gambro Renal Care Product Inc Company Profile

00:23 EDT 20th March 2018 | BioPortfolio

HOSPAL was founded in 1977 by the merger of the artificial kidney operations of two European chemical and pharmaceutical companies, Rhône-Poulenc and Sandoz. Both companies had been active in this rapidly developing field for a number of years. In combination, the new organisation gained the now famous high-flux AN69 membrane and the highly valued patented technology for the volumetric control of ultrafiltration.


10810 West Collins Ave
United States of America


Phone: 1/800 525 2623
Fax: 1/303 231 4032

News Articles [1150 Associated News Articles listed on BioPortfolio]

Integrating Kidney Transplantation Into Value-Based Care

The expansion of a comprehensive care model for the care of patients with renal failure will ensure the provision of quality care while reducing costs. American Journal of Transplantation

Renal transplant, previous breast cancer, and progressive breathlessness

A 68 year old woman presented with worsening shortness of breath on exertion. She had a history of polycystic kidney disease, chronic renal failure, renal transplant, and secondary...

Endocrinologist/nephrologist clinic found to reduce diabetic kidney disease progression

“Patients with type 2 diabetes and stage 3 or 4 chronic kidney disease who attended a joint endocrinologist-nephrologist diabetic kidney disease clinic were less likely to progress to end-stage ...

NICE recommends lenvatinib for the treatment of advanced renal cell carcinoma (RCC)

The National Institute for Health and Care Excellence (NICE) has given a positive recommendation for the use of lenvatinib in combination with everolimus for the treatment of adults with advanced rena...

UK’s NICE recommends Eusa Pharma’s Fotivda to treat advanced renal cell carcinoma

The UK’s National Institute for Health and Care Excellence (NICE) has recommended Eusa Pharma’s Fotivda (tivozanib) as a first line treatment for adult patients with advanced renal cell carcinoma ...

5 Top CKD Apps for Primary Care Physicians

Chronic renal disease is common in primary care settings and so are its comorbidities. In brief here, 5 apps you might want at hand.

Scleroderma renal crisis and renal involvement in systemic sclerosis

NICE recommends Eisai’s Kisplyx for renal cell carcinoma

The National Institute for Health and Care Excellence (NICE) has recommended the use of Eisai’s Kisplyx (lenvatinib) combined with everolimus...Read More... The post NICE recommends Eisai’s Kisply...

Drugs and Medications [36 Associated Drugs and Medications listed on BioPortfolio]

Prismasol [Gambro Renal Products]

PrismaSol Solution

Personal care antibacterial foaming hand wash [Personal Care Products, LLC]

Personal Care Antibacterial Foaming Hand Wash

Personal care [Personal Care Products, Inc.]

Personal Care Medicated Body Powder

Personal care [Personal Care Products, Inc.]

Personal Care Hand Sanitizer Antibacterial with Moisturizers and Vitamin E

Personal care petroleum jelly skin protectant [Personal Care Products, Inc]

Over 75 percent More Free Personal Care Petroleum Jelly Skin Protectant

PubMed Articles [5792 Associated PubMed Articles listed on BioPortfolio]

Assessment of renal function in routine care of people living with HIV on ART in a resource-limited setting in urban Zambia.

Data on renal impairment in sub-Saharan Africa (SSA) remains scarce, determination of renal function is not part of routine assessments. We evaluated renal function and blood pressure in a cohort of p...

Renal Replacement Therapy Modality in the ICU and Renal Recovery at Hospital Discharge.

Acute kidney injury requiring renal replacement therapy is a major concern in ICUs. Initial renal replacement therapy modality, continuous renal replacement therapy or intermittent hemodialysis, may i...

Interobserver agreement for post mortem renal histopathology and diagnosis of acute tubular necrosis in critically ill patients.

The renal histopathology of critically ill patients dying with acute kidney injury (AKI) in intensive care units of high income countries remains uncertain.

Cause of renal infarction: a retrospective analysis of 186 consecutive cases.

Renal infarction can cause abrupt and severe hypertension and less frequently renal failure. Renal infarction results from disruption of renal blood flow in the main ipsilateral renal artery or in a s...

Renal Resistive Index as a Novel Indicator for Renal Complications in High-Fat Diet-Fed Mice.

The renal resistive index (RI) is a novel candidate as a renal injury prognostic indicator, but it remains unclear how renal RI levels correspond to renal injury in diabetic nephropathy.

Clinical Trials [7782 Associated Clinical Trials listed on BioPortfolio]

Ease of Use Study for the Gambro Polyflux HD-C4 Small Dialyzer

The purpose of the study is to study the ease of use of the Polyflux HD-C4 Small dialyzer under conditions of routine clinical use for hemodialysis

European Trial of Free Light Chain Removal by Extended Haemodialysis in Cast Nephropathy

Hypothesis: Free light chain removal haemodialysis will increase the rate of renal recovery in patients with cast nephropathy, severe renal failure and de novo multiple myeloma. This stud...

Developing Of A New Incontinence Care Product

The aim of this randomized controlled clinical trial, prospective study is to developing a new incontinece care product for controlling the fecal and urinary incontinence and to examine th...

In Vivo Sun Protection Factor Determination

The study aims to determine the Sun Protection Factor (SPF) of 8 cosmetic products in vivo on the back of human participants, according to the International Standard Sun Protection Test me...

Lindi Product Satisfaction Survey

This study is being done because the investigators would like to evaluate product satisfaction of three test products (product A, product B, product C) that are available at any drug store...

Companies [2962 Associated Companies listed on BioPortfolio]

Gambro Inc.

Gambro’s business concept is to develop, manufacture, market and provide products and services within the areas of dialysis, intensive care, blood bank technology and therapeutics. Gambro is dedica...

Gambro Renal Care Product Inc

HOSPAL was founded in 1977 by the merger of the artificial kidney operations of two European chemical and pharmaceutical companies, Rhône-Poulenc and Sandoz. Both companies had been active in this ra...

Gambro BCT, Inc

Gambro BCT is an international company with operations in over 50 countries across the globe. Wherever we are, our commitment to building partnerships and better patient outcomes is unwavering

U.S. Renal Care, Inc.

Founded in 2000 by an experienced team of healthcare executives, U.S. Renal Care, Inc. works in partnership with nephrologists to develop, acquire, and operate outpatient treatment centers for persons...

Frenova Renal Research

Frenova is the world’s only drug and medical device contract clinical development services provider dedicated exclusively to renal research. As a Fresenius Medical Care North...

More Information about "Gambro Renal Care Product Inc" on BioPortfolio

We have published hundreds of Gambro Renal Care Product Inc news stories on BioPortfolio along with dozens of Gambro Renal Care Product Inc Clinical Trials and PubMed Articles about Gambro Renal Care Product Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Gambro Renal Care Product Inc Companies in our database. You can also find out about relevant Gambro Renal Care Product Inc Drugs and Medications on this site too.

Quick Search


Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Corporate Database Quicklinks

Searches Linking to this Company Record